Synopsis:
UniHealth Hospitals’ shares have surged over 85% in only seven sessions, attracting a lot of investor interest. The company is rapidly expanding across India and Africa with a hospital and consultancy model that promises high growth.
In this article, we will dive into the details of why the shares of this particular healthcare major are on the rise, such that it has risen over 108 percent in just seven trading sessions.
With a market capitalisation of Rs 523 crore, the shares of Unihealth Hospitals Ltd reached a day’s high of Rs 337.45 per share (upper circuit), up 5 percent from its previous day’s closing price of Rs 321.40 per share. In the last one year, the stock has delivered a robust return of 131 percent, outperforming NIFTY 50’s return of 12 percent.
About the Company
UniHealth is a healthcare enterprise that was launched in 2010 in Mumbai and has effectively extended its market to India and Africa. The group offers a vast range of medical services, such as hospitals, medical centres, healthcare consulting, hospital management, medical tourism, and distribution of medicines and medical supplies. The company’s mission is to provide quality healthcare at affordable prices to the entire community and, at the same time, uphold the quality standards in all its services.
UniHealth, through its brand ‘UMC Hospitals,’ runs hospital services for 200 beds in the three countries of Uganda, Nigeria, and Tanzania and is able to treat more than 100,000 patients annually. Besides that, the company is also involved in several consultancy projects, which in total exceed 1,000 new hospital beds. Having more than 500 employees and 150 doctors, UniHealth is one of the rapidly growing healthcare groups in Africa and is now further advancing in India to become a global healthcare provider.
Robust H1 Performance
Unihealth Hospitals reported a core revenue of Rs 67 crore in H1 FY26, a growth of 56 percent as compared to Rs 43 crore in H1 FY25. Additionally, it grew by 20 percent from Rs 56 crore in H2 FY25.
On the operating profit side, it reported an EBITDA of Rs 32 crore in H1 FY26, a staggering growth of 113 percent as compared to Rs 15 crore in H1 FY25. Additionally, it grew by 52 percent from Rs 21 crore in H2 FY25. Additionally, its margins has significantly risen from just 32 percent in September 2023 to a staggering 48 percent in September 2025, a growth of over 1,600 bps in just two years.
Regarding its profitability, it reported a net profit of Rs 29 crore in H1 FY26, a staggering growth of 222 percent as compared to Rs 9 crore in H1 FY25. Additionally, it recorded a growth of 61 percent from Rs 18 crore in H2 FY25.
Coming to its revenue segmentation for H1 FY26, the healthcare major derived a large 89.72 percent of its revenue from Medical Centres and Hospitals, followed by 4.15 percent from Export and Distribution of Pharmaceuticals & Medical Consumables, 2.01 percent from Consultancy Services and the remaining 4.11 percent from other income.
Coming to its geographical split, in FY25, the company derived a staggering 74.45 percent of its revenue from the Uganda region, followed by 15.81 percent from India, 7.71 percent from Nigeria, 1.10 from the UAE and the remaining 0.20 percent from Tanzania.
Future Outlook
UniHealth plans significant growth over the next three years by using a light asset model. The idea of the company is to lease hospital properties and operate them, thus expanding hospitals without the need to build from scratch. The company will add 1,000 beds through leased properties over 3 years. Addtion of 50-200 beds through boutique surgical hospitals in Mumbai, Pune, and Nashik, while targeting a healthy profitability of around 25 percent EBITDA.
UniHealth will not only expand in India, but also bolster its well-established operations in Africa, which are already running at high margins of nearly 35 percent EBITDA. By 2025, the company will be adding 120 new beds in Tanzania. Besides that, UniHealth intends to develop its Medical Value Travel (MVT) business by attracting more patients from Africa to India, a segment expected to grow fast during the upcoming years.
The firm is investing Rs 125 crore across India and Africa during 2024–26 to implement these growth plans. By FY27, UniHealth aims to achieve more than Rs 300 crore in revenue and 500+ hospital beds in India alone. With more than 1,300 beds under management through its consultancy division and several new hospitals at the stage of progress, UniHealth is gearing up for a robust multi-regional expansion.
Thus, UniHealth’s steep rally is a result of a strong earnings momentum, fast expansion in India and Africa, and an asset-light strategy that helps increase the company’s profitability. The company, with increasing hospital beds, rising medical travel, and ambitious targets for FY27, is making itself a healthcare player with high growth potential, which is the reason behind the sudden surge in investor interest.
Written by Satyajeet Mukherjee
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
